Adrenal Adenoma: Definition and Clinical Significance
An adrenal adenoma is a benign tumor originating from the adrenal cortex that may be non-functioning or hormone-producing, with most being incidentally discovered during imaging performed for unrelated reasons. 1
Characteristics and Prevalence
- Adrenal adenomas are the most common adrenal lesions, accounting for approximately 75% of all adrenal incidentalomas 1
- They typically appear as well-circumscribed, homogeneous masses with distinct imaging features
- Size is usually less than 4 cm, with larger size increasing risk of malignancy
- Prevalence is approximately 1-7% on cross-sectional abdominal imaging 2
Types of Adrenal Adenomas
Adrenal adenomas can be categorized based on their functional status:
Non-functioning Adenomas
- Most common type (approximately 75% of adrenal incidentalomas) 1
- Do not produce excess hormones
- Usually require no intervention if benign imaging characteristics are present
Functioning Adenomas
Cortisol-secreting adenomas (5.3% of adrenal incidentalomas) 1
- Can cause Cushing syndrome or mild autonomous cortisol secretion (MACS)
- MACS is diagnosed in 20-50% of patients with adrenal adenomas 2
Aldosterone-secreting adenomas (1% of adrenal incidentalomas) 1
- Cause primary hyperaldosteronism (Conn's syndrome)
- Present with hypertension and hypokalemia
Rarely, adenomas may secrete sex hormones
Diagnostic Evaluation
Imaging Features
- On non-contrast CT: Homogeneous, well-circumscribed mass with Hounsfield Units (HU) < 10 indicates benign adenoma 1, 3
- On contrast-enhanced CT: >60% washout at 15 minutes suggests benign lesion 3
- On MRI: Signal intensity loss in opposed-phase images indicates benign adenoma 1, 3
Hormonal Evaluation
All adrenal adenomas require complete hormonal workup regardless of imaging characteristics 3:
- 1mg overnight dexamethasone suppression test (cortisol ≤50 nmol/L or ≤1.8 µg/dL indicates normal suppression) 4
- Plasma or 24-hour urinary metanephrines (to exclude pheochromocytoma)
- Aldosterone-to-renin ratio if hypertension or hypokalemia present
Management Approach
Management is determined by:
- Functional status
- Size and imaging characteristics
- Risk of malignancy
Non-functioning Adenomas
- Benign-appearing adenomas <4 cm: No further imaging or functional testing needed 3
- Adenomas ≥4 cm: Consider surgical removal due to increased risk of malignancy 1, 3
- Indeterminate lesions: Repeat imaging in 3-6 months or surgical resection 3
Functioning Adenomas
Cortisol-producing adenomas:
Aldosterone-producing adenomas:
Distinguishing from Malignancy
Features suggesting malignancy (adrenocortical carcinoma) include:
- Size >4-5 cm
- Irregular margins
- Heterogeneous appearance
- HU >10 on non-contrast CT
- Poor contrast washout
- Local invasion or metastases 1
Clinical Implications and Follow-up
- For non-operated benign adenomas: Repeat imaging in 6-12 months; if growth >5mm/year, consider adrenalectomy 3
- After adrenalectomy for functioning adenomas: Temporary adrenal insufficiency may occur, requiring corticosteroid supplementation 1, 5
- Patients with MACS have increased risk of cardiovascular morbidity, frailty, fragility fractures, decreased quality of life, and increased mortality 2
Key Pitfalls to Avoid
- Failing to perform complete hormonal evaluation even for radiologically benign-appearing adenomas
- Performing biopsy of adrenal masses (contraindicated due to risk of tumor spillage and poor diagnostic power) 1
- Missing subclinical hormone production (especially MACS), which can lead to adverse health outcomes 5, 2
- Overlooking temporary adrenal insufficiency after surgery for functioning adenomas 1, 5
In summary, adrenal adenomas are common benign tumors that require careful evaluation of both imaging characteristics and hormonal function to guide appropriate management decisions.